Cue Biopharma, Inc. (CUE) vs Eledon Pharmaceuticals, Inc. (ELDN)
A side-by-side comparison of Cue Biopharma, Inc. and Eledon Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CUE
Cue Biopharma, Inc.
$23.82HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
ELDN
Eledon Pharmaceuticals, Inc.
$2.44HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Total return — CUE vs ELDN
growth of $100 · dividends reinvested · last 9yCUE -93.0% (-25.6%/yr)ELDN -96.6% (-31.3%/yr)CUE compounded faster over this window
CUE ELDN
CUE vs ELDN: by the numbers
- •ELDN is the larger company ($189M vs $173M market cap).
- •Both run net losses; ELDN's is the smaller (0.00% vs -435.83% net margin).
Metrics side by side
Valuation
| Metric | CUE | ELDN |
|---|---|---|
| P/S ratio | 4.60 | N/A |
| P/B ratio | 74.91 | 5.71 |
Profitability
| Metric | CUE | ELDN |
|---|---|---|
| Gross margin | 99.69% | 0.00% |
| Operating margin | -96.56% | 0.00% |
| Net margin | -435.83% | 0.00% |
| ROE | -7104.24% | -136.83% |
| ROIC | -1039.56% | -74.02% |
Growth (annualized)
| Metric | CUE | ELDN |
|---|---|---|
| Revenue CAGR (5Y) | 47.08% | N/A |
| Total return CAGR (5Y) | -42.42% | -15.17% |
Frequently asked
- How have CUE and ELDN total returns compared?
- Over the past 5 years, CUE delivered -42.42% and ELDN delivered -15.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cue Biopharma ROEEledon Pharmaceuticals ROECue Biopharma operating marginEledon Pharmaceuticals operating marginCue Biopharma revenue growthEledon Pharmaceuticals revenue growthCue Biopharma free cash flowEledon Pharmaceuticals free cash flow
Cue Biopharma & Eledon Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.